GranuFlo Lawsuit News: The Rottenstein Law Group LLP Notes the Submission of Proposed Cases For Bellwether Trials in Federal MDL

The firm is actively filing GranuFlo lawsuits on behalf of families who allege that their loved ones died as a result of being treated with a product called GranuFlo or NaturaLyte.

Print Email

Rockville Centre, March 31st, 2014 - Hundreds of GranuFlo lawsuits have been filed by plaintiffs who allege injuries caused by the kidney dialysis chemical, or by family members who have filed wrongful death claims on behalf of loved ones who suffered fatal cardiac events following routine dialysis treatments. The Rottenstein Law Group LLP acknowledges that cases consolidated into the GranuFlo multidistrict litigation currently underway in the U.S. District Court for the District of Massachusetts (In re: Fresenius GranuFlo/Naturalyte Dialysate Litigation, MDL No. 2428), are about to be chosen for upcoming bellwether trials, according to court documents. The Rottenstein Law Group, a GranuFlo law firm, maintains a an informational Web site at that is consistently updated to keep users informed of the latest developments concerning GranuFlo litigation.

Legal counsel representing Fresenius Medical Care, the manufacturer of GranuFlo, and plaintiffs, chose twenty cases out of the hundreds that have been consolidated into the MDL for possible bellwether trials. During a Status Conference that took place on March 28, both parties reviewed those cases, further reducing the number from which bellwether trials will be chosen from. Specific cases and trial dates will likely be announced soon.

“Bellwether trials are an especially important part of the legal process when it comes to personal injury litigation,” said Rochelle Rottenstein, principal of the Rottenstein Law Group. “These trials can help predict how juries will consider evidence in cases involving similar claims.”

Since the GranuFlo recall was announced in March 2012, lawsuits alleging that Fresenius Medical Care failed to warn physicians and patients about the dangers of receiving GranuFlo during dialysis treatments have been filed in federal and state courts across the country.  A New York Times article broke the news of an internal company memo that acknowledged a significant increase in patient deaths, apparently caused by inappropriate dosages of GranuFlo. The company did not publicly disclose this information, but when word leaked to the U.S. Food and Drug Administration (FDA), the company was forced to recall GranuFlo, and give strict instructions to its large network of dialysis clinics to cease administering it to patients.

The Rottenstein Law Group advises dialysis patients who have suffered injuries they believe were caused by GranuFlo, or survivors of loved ones who died shortly after a dialysis treatment that included GranuFlo, to speak to a qualified personal injury lawyer to determine if legal action is appropriate.

About The Rottenstein Law Group LLP
The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)

For More Information, Please Contact:
The Rottenstein Law Group LLP
Rochelle Rottenstein, Esq.
100 Merrick Road, Suite 226W
Rockville Centre, NY 11570
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)